When Surgery Alone Isn’t Enough: ALA-PDT Delivers a 23-Month Recurrence-Free Breakthrough for Periocular BCC
This article presents three cases of periocular basal cell carcinoma (pBCC) treated with palliative surgery followed by ALA-PDT, achieving clinical cure with no recurrence over 12-23 months and excellent cosmetic outcomes. This combined approach offers a feasible option when complete surgical resection is challenging.
